4D Molecular Therapeutics (NASDAQ:FDMT) and the U.S. FDA have reached agreement on a phase 3 trial design for diabetic macular edema (DME) candidate 4D-150. The company will only have to conduct a ...
Life Molecular Imaging (LMI), an international pharmaceutical company dedicated to developing and offering novel cutting-edge PET radiopharmaceuticals for imaging, announces that the U.S. Food and ...
We find that an attractive force makes tower building possible. Next, we explore the trade-offs between attraction and random motion to characterize the dynamics and phase transition of the tower ...
Transition metals have long been used as catalysts to activate small molecules and turn them into valuable products. However, as these metals can be expensive and less abundant, scientists are ...